CALGARY, ALBERTA--(Marketwire - Jan. 23, 2009) - Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) announces today, at the request of Investment Industry Regulatory Organization of Canada (IIROC) on behalf of the TSX Venture Exchange, that it is not aware of any corporate developments to account for the recent trading activity in SCT's stock.
